Home › Funds › Millennium Management › SAVA
Millennium Management position in SAVA
FILANA THERAPEUTICS INC
Latest position (Q1 2026)72.59K sh
Reported value held$122.67K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 126.85K | $7.88M | New |
| Q3 2022 | 9.05K | $379.00K | New |
| Q4 2022 | 20.90K | $617 | Add |
| Q1 2023 | 54.09K | $1.30K | Add |
| Q2 2023 | 9.31K | $228.35K | Reduce |
| Q4 2023 | 66.89K | $1.43M | New |
| Q4 2024 | 120.36K | $284.04K | New |
| Q2 2025 | 472.78K | $855.74K | New |
| Q3 2025 | 318.89K | $927.96K | Reduce |
| Q4 2025 | 274.40K | $543.31K | Reduce |
| Q1 2026 | 72.59K | $122.67K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SAVA
- Vanguard Group 2.38M sh · $4.70M · Q4 2025
- Two Sigma Investments 1.71M sh · $2.04M · Q2 2026
- Marshall Wace 1.60M sh · $1.90M · Q2 2026
- BlackRock Inc 1.45M sh · $1.73M · Q2 2026
- Geode Capital Management 615.51K sh · $732.74K · Q2 2026
- D. E. Shaw & Co 485.02K sh · $577.18K · Q2 2026
- BNY Mellon 20.28K sh · $24.14K · Q2 2026
- JPMorgan Chase & Co 17.03K sh · $20.78K · Q2 2026
- Morgan Stanley 13.56K sh · $16.14K · Q2 2026
- Wells Fargo & Co 10.47K sh · $12.45K · Q2 2026
- Fidelity Management & Research (FMR) 2.90K sh · $3.46K · Q2 2026
- T. Rowe Price Associates 40.86K sh · $49 · Q2 2026